CIK 0001731348
- Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- Operating
- EIN
- 824310622
- Phone
- +1 519-322-8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +58,204 | 199,489 | ||
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −30,849 | $4.88 | $151K | 168,640 |
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +120,017 | 288,657 | ||
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −63,610 | $4.88 | $310K | 225,047 |
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Performance Based Restricted Stock Units | −58,204 | 0 | ||
| 2026-08-26 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Performance Based Restricted Stock Units | −120,017 | 0 | ||
| 2026-08-03 | FALTISCHEK DENISE M Chief Strategy Officer | Purchase | +2,500 | $4.78 | $12K | 141,285 |
| 2026-07-30 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +26,120 | 152,629 | ||
| 2026-07-30 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −13,844 | $4.20 | $58K | 138,785 |
| 2026-07-30 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Restricted Stock Units | −26,120 | 0 | ||
| 2026-07-29 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +93,685 | 176,163 | ||
| 2026-07-29 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −49,654 | $3.99 | $198K | 126,509 |
| 2026-07-29 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Restricted Stock Units | −93,685 | 93,685 | ||
| 2026-07-29 | FALTISCHEK DENISE M Chief Strategy Officer | Grant or award · Restricted Stock Units | +281,901 | 281,901 | ||
| 2025-07-31 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +93,928 | $0.58 | $54K | 874,564 |
| 2025-07-31 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −49,782 | $0.58 | $29K | 824,782 |
| 2025-07-31 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Performance-Based Restricted Stock Units ("2022 PSUs") | −46,964 | 0 | ||
| 2025-07-30 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +261,194 | $0.61 | $159K | 919,069 |
| 2025-07-30 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −138,433 | $0.61 | $84K | 780,636 |
| 2025-07-30 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Restricted Stock Units | −261,194 | 261,194 |
Page 1 of 5 · 82 trades